134 related articles for article (PubMed ID: 30300358)
1. Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up.
Vogelzang EH; Hebing RCF; Nurmohamed MT; van Kuijk AWR; Kruijff JWF; l'Ami MJ; Krieckaert CLM; Wolbink G
PLoS One; 2018; 13(10):e0205125. PubMed ID: 30300358
[TBL] [Abstract][Full Text] [Related]
2. Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis.
Bonafede M; Johnson BH; Tang DH; Shah N; Harrison DJ; Collier DH
Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1656-63. PubMed ID: 26097194
[TBL] [Abstract][Full Text] [Related]
3. Persistence of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: An analysis of the South Korean National Health Insurance Database.
Lee MY; Shin JY; Park SY; Kim D; Cha HS; Lee EK
Semin Arthritis Rheum; 2018 Feb; 47(4):485-491. PubMed ID: 28939234
[TBL] [Abstract][Full Text] [Related]
4. [Non-adherence to biological therapy in patients with rheumatic diseases in the Brazilian Unified National Health System in Minas Gerais State, Brazil].
Dabés CG; Almeida AM; Acurcio Fde A
Cad Saude Publica; 2015 Dec; 31(12):2599-609. PubMed ID: 26872236
[TBL] [Abstract][Full Text] [Related]
5. Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis.
Bonafede M; Johnson BH; Princic N; Shah N; Harrison DJ
J Med Econ; 2015 May; 18(5):376-89. PubMed ID: 25530318
[TBL] [Abstract][Full Text] [Related]
6. Medication adherence and attrition to biologic treatment in rheumatoid arthritis patients.
Chu LH; Kawatkar AA; Gabriel SE
Clin Ther; 2015 Mar; 37(3):660-666.e8. PubMed ID: 25618317
[TBL] [Abstract][Full Text] [Related]
7. Utilization and adherence patterns of subcutaneously administered anti-tumor necrosis factor treatment among rheumatoid arthritis patients.
Tkacz J; Ellis L; Bolge SC; Meyer R; Brady BL; Ruetsch C
Clin Ther; 2014 May; 36(5):737-47. PubMed ID: 24661783
[TBL] [Abstract][Full Text] [Related]
8. Medication adherence and persistence in the treatment of rheumatoid arthritis with adalimumab and etanercept. Six years of analysis.
Santoleri F; Sorice P; Lasala R; Rizzo RC; Costantini A
J Med Econ; 2014 May; 17(5):320-5. PubMed ID: 24641160
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor-α/etanercept complexes in serum predict long-term efficacy of etanercept treatment in seronegative rheumatoid arthritis.
Berthold E; Månsson B; Gullstrand B; Geborek P; Saxne T; Bengtsson AA; Kahn R
Scand J Rheumatol; 2018 Jan; 47(1):22-26. PubMed ID: 28485187
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.
Jørgensen TS; Kristensen LE; Christensen R; Bliddal H; Lorenzen T; Hansen MS; Østergaard M; Jensen J; Zanjani L; Laursen T; Butt S; Dam MY; Lindegaard HM; Espesen J; Hendricks O; Kumar P; Kincses A; Larsen LH; Andersen M; Næser EK; Jensen DV; Grydehøj J; Unger B; Dufour N; Sørensen V; Vildhøj S; Hansen IM; Raun J; Krogh NS; Hetland ML
Rheumatology (Oxford); 2015 Dec; 54(12):2156-65. PubMed ID: 26175471
[TBL] [Abstract][Full Text] [Related]
11. Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis.
Accortt NA; Schenfeld J; Chang E; Papoyan E; Broder MS
Adv Ther; 2017 Sep; 34(9):2093-2103. PubMed ID: 28770517
[TBL] [Abstract][Full Text] [Related]
12. Haptoglobin-α1, -α2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis.
Blaschke S; Rinke K; Maring M; Flad T; Patschan S; Jahn O; Mueller CA; Mueller GA; Dihazi H
Arthritis Res Ther; 2015 Mar; 17(1):45. PubMed ID: 25884688
[TBL] [Abstract][Full Text] [Related]
13. Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
Hetland ML; Christensen IJ; Tarp U; Dreyer L; Hansen A; Hansen IT; Kollerup G; Linde L; Lindegaard HM; Poulsen UE; Schlemmer A; Jensen DV; Jensen S; Hostenkamp G; Østergaard M;
Arthritis Rheum; 2010 Jan; 62(1):22-32. PubMed ID: 20039405
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort.
Smith SL; Plant D; Eyre S; Hyrich K; Morgan AW; Wilson AG; Isaacs JD; Barton A
Rheumatology (Oxford); 2017 Jun; 56(6):1019-1024. PubMed ID: 28096457
[TBL] [Abstract][Full Text] [Related]
15. Effect of etanercept, infliximab and methotrexate in the treatment of arthritis.
Wang L; Liu Y; Su X; Liu S
Drug Res (Stuttg); 2015 Feb; 65(2):96-100. PubMed ID: 25050521
[TBL] [Abstract][Full Text] [Related]
16. Direct Comparative Effectiveness Among 3 Anti-Tumor Necrosis Factor Biologics in a Real-Life Cohort of Patients With Rheumatoid Arthritis.
Santos-Moreno P; Sánchez G; Gómez D; Bello-Gualtero J; Castro C
J Clin Rheumatol; 2016 Mar; 22(2):57-62. PubMed ID: 26886438
[TBL] [Abstract][Full Text] [Related]
17. Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up.
Kneepkens EL; Krieckaert CL; van der Kleij D; Nurmohamed MT; van der Horst-Bruinsma IE; Rispens T; Wolbink GJ
Ann Rheum Dis; 2015 Oct; 74(10):1825-9. PubMed ID: 24812290
[TBL] [Abstract][Full Text] [Related]
18. Adherence, discontinuation, and switching of biologic therapies in medicaid enrollees with rheumatoid arthritis.
Li P; Blum MA; Von Feldt J; Hennessy S; Doshi JA
Value Health; 2010; 13(6):805-12. PubMed ID: 21054657
[TBL] [Abstract][Full Text] [Related]
19. Serum interleukin-6 and survivin levels predict clinical response to etanercept treatment in patients with established rheumatoid arthritis.
Shi R; Chen M; Litifu B
Mod Rheumatol; 2018 Jan; 28(1):126-132. PubMed ID: 28657833
[TBL] [Abstract][Full Text] [Related]
20. ¹H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis.
Priori R; Casadei L; Valerio M; Scrivo R; Valesini G; Manetti C
PLoS One; 2015; 10(11):e0138537. PubMed ID: 26558759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
